{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:48:13Z","timestamp":1780069693954,"version":"3.54.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004593","name":"Universidad Autonoma de Madrid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.eprac.2024.09.011","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T19:49:15Z","timestamp":1727293755000},"page":"1134-1140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of 1-Hour Postload Plasma Glucose, the Metabolic Syndrome, and the Finish Diabetes Risk Score in the Prediction of Type 2 Diabetes"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4542-8679","authenticated-orcid":false,"given":"Juan Carlos","family":"Lizarzaburu-Robles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alonso","family":"Garro-Mendiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Lazo-Porras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba Gald\u00f3n","family":"Sanz-Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flor","family":"Vento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.eprac.2024.09.011_bib1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.eprac.2024.09.011_bib2","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1210\/jc.2018-00468","article-title":"One-hour postload hyperglycemia: implications for prediction and prevention of type 2 diabetes","volume":"103","author":"Fiorentino","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2024.09.011_bib3","doi-asserted-by":"crossref","first-page":"888","DOI":"10.2337\/diacare.28.4.888","article-title":"Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program","volume":"28","author":"Ratner","year":"2005","journal-title":"Diabetes Care"},{"issue":"16","key":"10.1016\/j.eprac.2024.09.011_bib4","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.eprac.2024.09.011_bib5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2337\/diacare.26.3.725","article-title":"The diabetes risk score: a practical tool to predict type 2 diabetes risk","volume":"26","author":"Lindstr\u00f6m","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2024.09.011_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108558","article-title":"The Finnish Diabetes Risk Score (FINDRISC), incident diabetes and low-grade inflammation","volume":"171","author":"Pesaro","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"10.1016\/j.eprac.2024.09.011_bib7","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/archinternmed.2010.66","article-title":"Barriers to routine risk-score use for healthy primary care patients: survey and qualitative study","volume":"170","author":"M\u00fcller-Riemenschneider","year":"2010","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.eprac.2024.09.011_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.15381\/anales.v74i4.2705","article-title":"S\u00edndrome metab\u00f3lico: concepto y aplicaci\u00f3n pr\u00e1ctica","volume":"74","author":"Lizarzaburu Robles","year":"2014","journal-title":"An Fac Med"},{"key":"10.1016\/j.eprac.2024.09.011_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.725314","article-title":"Comparison of the Finnish Diabetes Risk Score model with the metabolic syndrome in a Shanghai population","volume":"13","author":"Jin","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10.1016\/j.eprac.2024.09.011_bib10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.pcd.2018.07.015","article-title":"Diagnostic accuracy of the Finnish Diabetes Risk Score (FINDRISC) for undiagnosed T2DM in Peruvian population","volume":"12","author":"Bernabe-Ortiz","year":"2018","journal-title":"Prim Care Diabetes"},{"issue":"1","key":"10.1016\/j.eprac.2024.09.011_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13098-018-0310-0","article-title":"Predicting type 2 diabetes mellitus: a comparison between the FINDRISC score and the metabolic syndrome","volume":"10","author":"Meijnikman","year":"2018","journal-title":"Diabetol Metab Syndr"},{"issue":"7","key":"10.1016\/j.eprac.2024.09.011_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158489","article-title":"Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a community-based, cross-sectional programme for screening of undiagnosed type 2 diabetes mellitus and dysglycaemia in Madrid, Spain: the SPREDIA-2 Study","volume":"11","author":"Salinero-Fort","year":"2016","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.eprac.2024.09.011_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000769","article-title":"Validity of the FINDRISC as a prediction tool for diabetes in a contemporary Norwegian population: a 10-year follow-up of the HUNT study","volume":"7","author":"J\u00f8lle","year":"2019","journal-title":"BMJ Open Diab Res Care"},{"issue":"3-4","key":"10.1016\/j.eprac.2024.09.011_bib14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.aogh.2017.07.001","article-title":"Transculturalizing diabetes prevention in Latin America","volume":"83","author":"Nieto-Mart\u00ednez","year":"2017","journal-title":"Ann Glob Health"},{"issue":"9","key":"10.1016\/j.eprac.2024.09.011_bib15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.medcli.2011.05.025","article-title":"Validaci\u00f3n del FINDRISC (FINnish Diabetes Risk SCore) para la predicci\u00f3n del riesgo de diabetes tipo 2 en una poblaci\u00f3n del sur de Espa\u00f1a. Estudio Pizarra","volume":"138","author":"Soriguer","year":"2012","journal-title":"Med Cl\u00edn"},{"issue":"1","key":"10.1016\/j.eprac.2024.09.011_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1146\/annurev-publhealth-090419-102644","article-title":"Prediabetes and what it means: the epidemiological evidence","volume":"42","author":"Echouffo-Tcheugui","year":"2021","journal-title":"Annu Rev Public Health"},{"issue":"Supplement 1","key":"10.1016\/j.eprac.2024.09.011_bib17","first-page":"S15","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.eprac.2024.09.011_bib18","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2337\/dc06-1331","article-title":"What is the best predictor of future type 2 diabetes?","volume":"30","author":"Abdul-Ghani","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2024.09.011_bib19","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.2147\/DMSO.S246062","article-title":"The oral glucose tolerance test: 100 years later","volume":"13","author":"Jagannathan","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"2","key":"10.1016\/j.eprac.2024.09.011_bib20","first-page":"539","article-title":"1-hour and 2-hour postload glucose level on oral glucose tolerance test and the risk of incident metabolic syndrome","volume":"104","author":"Park","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2024.09.011_bib21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4158\/EP-2019-0387","article-title":"A\u00a0cross-sectional study of the association between the 1-hour oral glucose tolerance test and the metabolic syndrome in a high-risk sample with impaired fasting glucose","volume":"26","author":"Lizarzaburu-Robles","year":"2020","journal-title":"Endocr Pract"},{"issue":"8","key":"10.1016\/j.eprac.2024.09.011_bib22","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2337\/dc08-0225","article-title":"One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes","volume":"31","author":"Abdul-Ghani","year":"2008","journal-title":"Diabetes Care"},{"issue":"Supplement_1","key":"10.1016\/j.eprac.2024.09.011_bib23","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and diagnosis of diabetes: standards of care in diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"91","key":"10.1016\/j.eprac.2024.09.011_bib24","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.24875\/ALAD.19000369","article-title":"Consenso ALAD. Tratamiento del paciente con diabetes mellitus tipo 2 y obesidad","volume":"9","author":"Brajkovich","year":"2019","journal-title":"ALAD"},{"issue":"9833","key":"10.1016\/j.eprac.2024.09.011_bib25","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","article-title":"Prediabetes: a high-risk state for diabetes development","volume":"379","author":"Tab\u00e1k","year":"2012","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.eprac.2024.09.011_bib26","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.2337\/diacare.27.11.2676","article-title":"Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and\/or cardiovascular disease?","volume":"27","author":"Stern","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2024.09.011_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.diabres.2018.09.017","article-title":"Petition to replace current OGTT criteria for diagnosing prediabetes with the 1-hour post-load plasma glucose \u2265 155 mg\/dl (8.6 mmol\/L)","volume":"146","author":"Bergman","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.eprac.2024.09.011_bib28","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.24875\/ALAD.20000409","article-title":"Prediabetes en Per\u00fa: consenso de expertos","volume":"10","author":"Secl\u00e9n-Santiesteban","year":"2020","journal-title":"ALAD"},{"issue":"1","key":"10.1016\/j.eprac.2024.09.011_bib29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12916-019-1440-4","article-title":"Insulin resistance and systemic metabolic changes in oral glucose tolerance test in 5340 individuals: an interventional study","volume":"17","author":"Wang","year":"2019","journal-title":"BMC Med"},{"issue":"4","key":"10.1016\/j.eprac.2024.09.011_bib30","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.2337\/dc20-1688","article-title":"Accuracy of 1-hour plasma glucose during the oral glucose tolerance test in diagnosis of type 2 diabetes in adults: a meta-analysis","volume":"44","author":"Ahuja","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2024.09.011_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.752329","article-title":"The 1-hour plasma glucose: common link across the glycemic spectrum","volume":"12","author":"Bergman","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10.1016\/j.eprac.2024.09.011_bib32","article-title":"Oxidative stress and inflammatory markers in prediabetes and diabetes","volume":"70","author":"Luc","year":"2019","journal-title":"J\u00a0Physiol Pharmacol"},{"key":"10.1016\/j.eprac.2024.09.011_bib33","first-page":"D6989","article-title":"Medisch-specialistische richtlijnen op de werkvloer [The role of clinical guidelines in daily practice]","volume":"166","author":"Weller","year":"2022","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"1","key":"10.1016\/j.eprac.2024.09.011_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/bmjhci-2020-100253","article-title":"Adoption of clinical risk prediction tools is limited by a lack of integration with electronic health records","volume":"28","author":"Sharma","year":"2021","journal-title":"BMJ Health Care Inform"},{"issue":"693","key":"10.1016\/j.eprac.2024.09.011_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3399\/bjgp20X708941","article-title":"Clinical scores in primary care","volume":"70","author":"Dambha-Miller","year":"2020","journal-title":"Br J Gen Pract"},{"issue":"2","key":"10.1016\/j.eprac.2024.09.011_bib36","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3390\/ijms23020786","article-title":"Metabolic syndrome: updates on pathophysiology and management in 2021","volume":"23","author":"Fahed","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.eprac.2024.09.011_bib37","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.5114\/aoms\/152921","volume":"18","author":"Dobrowolski","year":"2022","journal-title":"Arch Med Sci"},{"issue":"5","key":"10.1016\/j.eprac.2024.09.011_bib38","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.pcd.2020.02.008","article-title":"Performance of the Finnish Diabetes Risk Score (FINDRISC) and Modified Asian FINDRISC (ModAsian FINDRISC) for screening of undiagnosed type 2 diabetes mellitus and dysglycaemia in primary care","volume":"14","author":"Lim","year":"2020","journal-title":"Prim Care Diabetes"},{"issue":"1","key":"10.1016\/j.eprac.2024.09.011_bib39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2337\/ds16-0051","article-title":"Diabetes risk assessment in latinas: effectiveness of a brief diabetes risk questionnaire for detecting prediabetes in a community-based sample","volume":"31","author":"Scanlan","year":"2018","journal-title":"Diabetes Spectr"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24006773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24006773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T09:38:45Z","timestamp":1733132325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X24006773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1530891X24006773"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2024.09.011","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of 1-Hour Postload Plasma Glucose, the Metabolic Syndrome, and the Finish Diabetes Risk Score in the Prediction of Type 2 Diabetes","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2024.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}